In Brief: Lifecore
This article was originally published in The Gray Sheet
Lifecore: Chaska, Minnesota-based company signs an agreement for the supply of sodium hyaluronate to Swiss firm Chemedica S.A. The deal "anticipates $1.8 mil. of medical-grade product purchases by Chemedica during the period of calendar 1996 and 1997," Lifecore says...
You may also be interested in...
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.